ATLASATLAS fair value
ATLAS has no fair value for this stock today.
Clariane (CLARI.PA)
Clariane stock price today, ATLAS forecast and fair value
Healthcare · Medical Care Facilities · Euronext Paris · France
€3.15▲ +1.42%
Prices as of Oct 27, 2026 · EUR
Chance of rising in 1 month
49%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Clariane in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Clariane
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives Clariane a 49% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between €2.90 and €3.40; in 9 out of 10, between €2.53 and €3.91. Estimated annual volatility is 37%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- €1.2B
- Market cap (USD)
- $1.3B
- P/E ratio
- 109.2
- 52-week high
- €4.42
- 52-week low
- €2.98
- Revenue (12 months)
- €5.4B
- Gross margin
- 31.3%
- Operating margin
- 5.8%
- Net margin
- 0.2%
- Beta
- 0.81
What this means
ATLAS does not publish a fair value for CLARI.PA right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks CLARI.PA has traded between €2.98 and €4.42. Today it is 28.8% below that high and 6% above its low.
On the business: net margin is 0.2%; it trades at 109.2 times earnings.
Its beta is 0.81: it tends to move less than the market.
About the company
Clariane SE provides care homes, healthcare facilities and services, and shared living solutions in France, Germany, Benelux, Italy, Spain, and the United Kingdom. It operates long-term care and short stay nursing homes.
Want to see everything about Clariane?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does Clariane do?
Clariane SE provides care homes, healthcare facilities and services, and shared living solutions in France, Germany, Benelux, Italy, Spain, and the United Kingdom. It operates long-term care and short stay nursing homes.
What is the chance CLARI.PA goes up next month?
49%: close to a coin flip. In half of the simulated outcomes, CLARI.PA ends the month between €2.90 and €3.40.
How big is Clariane and what is its P/E ratio?
Clariane's market capitalization is €1.2B. Its price-to-earnings (P/E) ratio is 109.2: you pay €109.2 for each €1.00 of yearly earnings.
How volatile is CLARI.PA?
ATLAS estimates annual volatility at 37%. In a typical month, half of the outcomes end between €2.90 and €3.40.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer